Philip Morris International Inc. (PM)
- Previous Close
96.09 - Open
95.80 - Bid 95.01 x 1200
- Ask 95.13 x 800
- Day's Range
94.94 - 96.62 - 52 Week Range
87.23 - 100.79 - Volume
5,389,772 - Avg. Volume
6,106,074 - Market Cap (intraday)
147.714B - Beta (5Y Monthly) 0.64
- PE Ratio (TTM)
18.56 - EPS (TTM)
5.12 - Earnings Date Jul 23, 2024
- Forward Dividend & Yield 5.20 (5.47%)
- Ex-Dividend Date Mar 20, 2024
- 1y Target Est
108.97
Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness and healthcare products. Philip Morris International Inc. was incorporated in 1987 and is headquartered in Stamford, Connecticut.
www.pmi.comRecent News: PM
Performance Overview: PM
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PM
Valuation Measures
Market Cap
147.71B
Enterprise Value
194.13B
Trailing P/E
18.56
Forward P/E
15.20
PEG Ratio (5yr expected)
2.18
Price/Sales (ttm)
4.11
Price/Book (mrq)
--
Enterprise Value/Revenue
5.40
Enterprise Value/EBITDA
15.79
Financial Highlights
Profitability and Income Statement
Profit Margin
22.16%
Return on Assets (ttm)
12.77%
Return on Equity (ttm)
--
Revenue (ttm)
35.95B
Net Income Avi to Common (ttm)
7.94B
Diluted EPS (ttm)
5.12
Balance Sheet and Cash Flow
Total Cash (mrq)
3.97B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: PM
Company Insights: PM
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: PM
Analyst Report: Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from cigarettes with the acquisition in 2022 of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches, primarily in the US and Scandinavia. It diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
RatingPrice TargetAnalyst Report: Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from cigarettes with the acquisition in 2022 of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches, primarily in the US and Scandinavia. It diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
RatingPrice TargetLarge Cap US Pick List - April 2024
This pick list highlights constituents of the Morningstar US Large Cap Index that we believe offer investors the best risk-adjusted return prospects. Stocks of large-cap companies where neither growth nor value characteristics predominate. Stocks in the top 70% of the capitalization of the U.S. equity market are defined as large cap.
Analyst Report: Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from cigarettes with the acquisition in 2022 of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches, primarily in the US and Scandinavia. It diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
RatingPrice Target